Title: Controlled trial of cyclosporine (0.05%) versus Olopatadine (0.2%) topical solution in treatment of vernal keratoconjuntivitis
Authors: Dr Kriti Nema, Dr Ashish Nema, Dr Sadiya Hussain
DOI: https://dx.doi.org/10.18535/jmscr/v6i7.74
Abstract
A randomized controlled study was conducted at such sagar medical college, Jabalpur for comparative analysis of topical cyclosporine (0.05%) and olopatadine (0.2%) in patients of vernal keratoconjuctivitis. Total number of patients specified for study was 62 among which 30 patients received cyclosporine and 32 received olopatadine. Improvement in signs and symptoms was assessed for a period of one month. As a result both treatment modalities were found to be safe and effective in treating VKC. In 1st week Olopatadine was more effective but thereafter no statistically significant difference could be observed in their efficacy.
References
- J Mendicute. Topical cyclosporine 2% in the treatment of vernal keratoconjuctivitis. Eye;(1997)11:75-8.
- Esen Karamural, Akpek. A randomized trial of low dose Mitomycin c in treatment of VKC. Ophthalmology;Vol 107:Feb 2000,263-9.
- Bonini S Bonini. Ige and non-ige mechanisms in ocular allergy, 1993.
- Pucci, Neri. Anal of allergy, asthma and immunology 2002;89:298-300.
- Bonini s bonini. VKC Revisited. Ophyhalmology 107;2000:1157-63.